血栓
医学
冲程(发动机)
内科学
血运重建
病因学
心脏病学
血栓栓塞性中风
梗塞
心肌梗塞
机械工程
工程类
心房颤动
作者
Hisao SHIMIZU,Kinta Hatakeyama,Katsumi Saito,Ryogo Shobatake,Nobuyuki Takahashi,Jun Deguchi,Hidemori Tokunaga,Keiji Shimada,Ichiro Nakagawa,Kaoru Myochin,Kazuya Sakai,Masayuki Kubo,Atsushi Yamashita,Chiho Obayashi,Kazuma Sugie,Masanori Matsumoto
标识
DOI:10.1016/j.thromres.2022.09.004
摘要
Understanding the composition of stroke thrombi retrieved by mechanical thrombectomy is essential to clarify the pathogenesis of stroke. However, it is difficult to evaluate thrombus composition precisely and objectively. Immunohistochemical staining was used to evaluate thrombus composition and age.Consecutive thrombi (n = 108) retrieved from patients who underwent mechanical thrombectomy for acute large-vessel ischemic stroke were retrospectively analyzed. Lytic features of granulocytes and CD163 were estimated as indicators of the age of the cardioembolic (CE) thrombus.The stroke subtypes were as follows: CE, 74 cases; large artery atherosclerosis, 11; undetermined etiology, 12; and other determined etiology, 11. There were no statistical differences in thrombi composition according to stroke subtypes. The fibrin area was positively correlated with the red blood cell (RBC) and platelet areas. The following analysis was performed using CE only. Regarding age, the thrombus was judged as fresh in 30.0 % and older in 70.0 % based on the lytic features. The RBC areas of older thrombi were smaller than those of fresh thrombi. The puncture-to-reperfusion time of older thrombi was longer than that of fresh thrombi. Platelet-rich thrombi were associated with a greater number of maneuvers, a smaller prevalence of TICI 3, and unfavorable functional outcomes compared to platelet-poor thrombi. The number of CD163 positive cells in thrombi with anticoagulants was higher than in those without anticoagulants.Thrombus composition correlated with revascularization and clinical outcomes. The composition of an acute ischemic thrombus may reflect the pathophysiology of stroke and influence treatment efficacy.
科研通智能强力驱动
Strongly Powered by AbleSci AI